{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:44:43Z","timestamp":1777005883113,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T00:00:00Z","timestamp":1723248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, & Immunity - Health"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bbih.2024.100842","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T13:00:44Z","timestamp":1723640444000},"page":"100842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The novel schizophrenia subgroup \u201cmajor neurocognitive psychosis\u201d is validated as a distinct class through the analysis of immune-linked neurotoxicity biomarkers and neurocognitive deficits"],"prefix":"10.1016","volume":"40","author":[{"given":"Petar","family":"Popov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein Kadhem","family":"Al-Hakeim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Fattah","family":"Al-Musawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arafat Hussein","family":"Al-Dujaili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drozdstoy","family":"Stoyanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbih.2024.100842_bib1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s12640-019-00112-z","article-title":"The neuroimmune and neurotoxic fingerprint of major neurocognitive psychosis or deficit schizophrenia: a supervised machine learning study","volume":"37","author":"Al-Hakeim","year":"2020","journal-title":"Neurotox. Res."},{"issue":"9","key":"10.1016\/j.bbih.2024.100842_bib2","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2174\/1568026620666200128143948","article-title":"Construction of a neuro-immune-cognitive pathway-phenotype under-pinning the phenome of deficit schizophrenia","volume":"20","author":"Al-Hakeim","year":"2020","journal-title":"Current topics in medicinal chemistry"},{"issue":"10","key":"10.1016\/j.bbih.2024.100842_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0275839","article-title":"The interleukin-6\/interleukin-23\/T helper 17-axis as a driver of neuro-immune toxicity in the major neurocognitive psychosis or deficit schizophrenia: a precision nomothetic psychiatry analysis","volume":"17","author":"Al-Hakeim","year":"2022","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.bbih.2024.100842_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192215281","article-title":"In schizophrenia, the effects of the IL-6\/IL-23\/Th17 Axis on health-related quality of life and disabilities are partly mediated by generalized cognitive decline and the symptomatome","volume":"19","author":"Al-Musawi","year":"2022","journal-title":"Int. J. Environ. Res. Publ. Health"},{"issue":"4","key":"10.1016\/j.bbih.2024.100842_bib5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1017\/S1092852920001182","article-title":"Schizophrenia phenomenology revisited: positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severity of schizophrenia","volume":"26","author":"Almulla","year":"2021","journal-title":"CNS Spectr."},{"issue":"12","key":"10.1016\/j.bbih.2024.100842_bib6","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.5498\/wjp.v11.i12.1274","article-title":"Differential aberrant connectivity of precuneus and anterior insula may underpin the diagnosis of schizophrenia and mood disorders","volume":"11","author":"Aryutova","year":"2021","journal-title":"World J. Psychiatr."},{"key":"10.1016\/j.bbih.2024.100842_bib7","series-title":"Eugen Bleuler's Place in the History of Psychiatry","first-page":"1095","author":"Berrios","year":"2011"},{"issue":"2","key":"10.1016\/j.bbih.2024.100842_bib8","first-page":"111","article-title":"Schizophrenia: a conceptual history","volume":"3","author":"Berrios","year":"2003","journal-title":"Int. J. Psychol. Psychol. Ther."},{"issue":"10","key":"10.1016\/j.bbih.2024.100842_bib9","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1176\/ajp.146.10.1267","article-title":"Simple schizophrenia: past, present, and future","volume":"146","author":"Black","year":"1989","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.bbih.2024.100842_bib10","series-title":"Translated by J. Zinkin","first-page":"1911","article-title":"Dementia praecox on the group of schizophrenia","author":"Bleuler","year":"1911"},{"key":"10.1016\/j.bbih.2024.100842_bib11","series-title":"Emil Kraepelin","author":"Britannica","year":"2024"},{"issue":"3","key":"10.1016\/j.bbih.2024.100842_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/0957154X07078976","article-title":"How kraepelinian was Kraepelin? How kraepelinian are the neo-Kraepelinians?\u2014from Emil Kraepelin to DSM-III","volume":"18","author":"Decker","year":"2007","journal-title":"Hist. Psychiatr."},{"issue":"1","key":"10.1016\/j.bbih.2024.100842_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.5604\/12321966.1233566","article-title":"Social functioning and the quality of life of patients diagnosed with schizophrenia","volume":"25","author":"Dziwota","year":"2018","journal-title":"Ann. Agric. Environ. Med."},{"issue":"2","key":"10.1016\/j.bbih.2024.100842_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4103\/0019-5545.64591","article-title":"Emil Kraepelin: a pioneer of scientific understanding of psychiatry and psychopharmacology","volume":"52","author":"Ebert","year":"2010","journal-title":"Indian J. Psychiatr."},{"issue":"10","key":"10.1016\/j.bbih.2024.100842_bib16","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1176\/ajp.2006.163.10.1710","article-title":"Emil wilhelm Magnus Georg Kraepelin (1856\u20131926)","volume":"163","author":"Engstrom","year":"2006","journal-title":"Am. J. Psychiatr."},{"issue":"2","key":"10.1016\/j.bbih.2024.100842_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/wps.20629","article-title":"Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study","volume":"18","author":"Guloksuz","year":"2019","journal-title":"World Psychiatr."},{"issue":"4","key":"10.1016\/j.bbih.2024.100842_bib19","first-page":"81","article-title":"Hamilton anxiety rating scale (HAM-A)","volume":"61","author":"Hamilton","year":"1959","journal-title":"J. Med."},{"issue":"1","key":"10.1016\/j.bbih.2024.100842_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"3","key":"10.1016\/j.bbih.2024.100842_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.31887\/DCNS.2010.12.3\/ajablensky","article-title":"The diagnostic concept of schizophrenia: its history, evolution, and future prospects","volume":"12","author":"Jablensky","year":"2010","journal-title":"Dialogues Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.bbih.2024.100842_bib22","first-page":"1","article-title":"Epidemiology and risk factors of schizophrenia","volume":"37","author":"Janoutov\u00e1","year":"2016","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.bbih.2024.100842_bib23","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s11011-017-9982-7","article-title":"Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway","volume":"32","author":"Kanchanatawan","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbih.2024.100842_bib24","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1007\/s12035-017-0465-y","article-title":"Deficit schizophrenia is characterized by defects in IgM-mediated responses to tryptophan catabolites (TRYCATs): a paradigm shift towards defects in natural self-regulatory immune responses coupled with mucosa-derived TRYCAT pathway activation","volume":"55","author":"Kanchanatawan","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.bbih.2024.100842_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11011-018-0339-7","article-title":"Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia","volume":"34","author":"Kanchanatawan","year":"2019","journal-title":"Metab. Brain Dis."},{"issue":"2","key":"10.1016\/j.bbih.2024.100842_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"2\u20133","key":"10.1016\/j.bbih.2024.100842_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.schres.2003.09.011","article-title":"The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery","volume":"68","author":"Keefe","year":"2004","journal-title":"Schizophrenia research"},{"key":"10.1016\/j.bbih.2024.100842_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-clinpsy-032813-153657","article-title":"Excess early mortality in schizophrenia","volume":"10","author":"Laursen","year":"2014","journal-title":"Annu. Rev. Clin. Psychol."},{"issue":"3","key":"10.1016\/j.bbih.2024.100842_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/neu.2022.32","article-title":"Major neurocognitive psychosis: a novel schizophrenia endophenotype class that is based on machine learning and resembles Kraepelin's and Bleuler's conceptions","volume":"35","author":"Maes","year":"2023","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.bbih.2024.100842_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.663985","article-title":"False dogmas in schizophrenia research: toward the reification of pathway phenotypes and pathway classes","volume":"12","author":"Maes","year":"2021","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.bbih.2024.100842_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1092852921000419","article-title":"In (deficit) schizophrenia, a general cognitive decline partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and quality of life","author":"Maes","year":"2021","journal-title":"CNS Spectr."},{"issue":"1","key":"10.1016\/j.bbih.2024.100842_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0165-1781(90)90057-C","article-title":"Clinical subtypes of unipolar depression: Part II. Quantitative and qualitative clinical differences between the vital and nonvital depression groups","volume":"34","author":"Maes","year":"1990","journal-title":"Psychiatr. Res."},{"issue":"5","key":"10.1016\/j.bbih.2024.100842_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/15622975.2019.1701203","article-title":"In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde","volume":"21","author":"Maes","year":"2020","journal-title":"World J. Biol. Psychiatr."},{"issue":"3","key":"10.1016\/j.bbih.2024.100842_bib34","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/schbul\/sbr016","article-title":"Eugen Bleuler's Dementia praecox or the group of schizophrenias (1911): a centenary appreciation and reconsideration","volume":"37","author":"Moskowitz","year":"2011","journal-title":"Schizophr. Bull."},{"issue":"S7","key":"10.1016\/j.bbih.2024.100842_bib35","first-page":"49","article-title":"The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations","volume":"155","author":"NCJTBJoP","year":"1989"},{"issue":"2","key":"10.1016\/j.bbih.2024.100842_bib36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/bs.3830080203","article-title":"A pattern probability model for the classification of psychiatric patients","volume":"8","author":"Overall","year":"1963","journal-title":"Behav. Sci."},{"key":"10.1016\/j.bbih.2024.100842_bib37","series-title":"Clinical Psychopathology. (Trans. By M. W. Hamilton)","first-page":"173","author":"Schneider","year":"1959"},{"issue":"2","key":"10.1016\/j.bbih.2024.100842_bib38","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1192\/bjp.167.2.174","article-title":"Two faces of Emil Kraepelin","volume":"167","author":"Shepherd","year":"1995","journal-title":"Br. J. Psychiatr."},{"key":"10.1016\/j.bbih.2024.100842_bib39","first-page":"151","article-title":"Symptom, syndrome, disease: a clinical method in psychiatry","author":"Snezhnevsky","year":"1971","journal-title":"The world biennial of psychiatry and psychotherapy"},{"key":"10.1016\/j.bbih.2024.100842_bib40","series-title":"The Forms of Schizophrenia and Their Biological Correlates. Biochemistry, Schizophrenias, and Affective Illnesses","first-page":"1","author":"Snezhnevsky","year":"1970"},{"issue":"4","key":"10.1016\/j.bbih.2024.100842_bib41","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/schbul\/sbv061","article-title":"First rank symptoms for schizophrenia (Cochrane diagnostic test accuracy review)","volume":"41","author":"Soares-Weiser","year":"2015","journal-title":"Schizophr. Bull."}],"container-title":["Brain, Behavior, & Immunity - Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354624001200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354624001200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T19:23:13Z","timestamp":1726428193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666354624001200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":39,"alternative-id":["S2666354624001200"],"URL":"https:\/\/doi.org\/10.1016\/j.bbih.2024.100842","relation":{},"ISSN":["2666-3546"],"issn-type":[{"value":"2666-3546","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The novel schizophrenia subgroup \u201cmajor neurocognitive psychosis\u201d is validated as a distinct class through the analysis of immune-linked neurotoxicity biomarkers and neurocognitive deficits","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, & Immunity - Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbih.2024.100842","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100842"}}